ARTICLE

FindCenter AddIcon

Largest Ever Psychedelics Study Maps Changes of Conscious Awareness to Neurotransmitter Systems

By Neuroscience News — 2022

In the world’s largest study on psychedelics and the brain, a team of researchers from The Neuro (Montreal Neurological Institute-Hospital) and Department of Biomedical Engineering of McGill University, the Broad Institute at Harvard/MIT, SUNY Downstate Health Sciences University, and Mila—Quebec Artificial Intelligence Institute have shown how drug-induced changes in subjective awareness are anatomically rooted in specific neurotransmitter receptor systems.

Read on neurosciencenews.com

FindCenter Post-Image

Crash Course in the Nature of Mind

Roland Griffiths' psilocybin experiments have produced striking evidence for therapeutic uses of hallucinogens.

Article
Julie Scharper
FindCenter AddIcon
FindCenter Post-Image

Psilocybin Sessions: Psychedelics Could Help People with Addiction and Anxiety

Study participants at some of the country's leading medical research centers are going through intense therapy and six-hour psychedelic journeys deep into their minds to do things like quit smoking and worry less.

Article
Anderson Cooper
2019
FindCenter AddIcon
FindCenter Post-Image

‘60 Minutes’ Segment Explores Psychedelics Research at Johns Hopkins

Scientists Roland Griffiths and Matthew Johnson sit down with journalist Anderson Cooper to discuss the promise of psychedelics as a form of treatment for anxiety, depression, addiction, and more.

Article
60 Minutes
2019
FindCenter AddIcon
FindCenter Post-Image

Roland Griffiths: 5 Fast Facts You Need to Know

Roland Griffiths is a Johns Hopkins University professor, researcher and expert in the field of pharmacology. He is best known for his research into the beneficial effects psilocybin on cancer patients.

Article
Alyssa Choiniere
2019
FindCenter AddIcon
FindCenter Post-Image

Scientists Gave Depressed Patients Psilocybin in a First for Psychedelic Therapy

In a recent UK trial, 12 patients with major depression took a pill quite different to commonly prescribed antidepressants: 25mg of psilocybin, the psychedelic compound found in magic mushrooms.

Article
Victoria Turk
2016
FindCenter AddIcon
FindCenter Post-Image

We Can No Longer Ignore the Potential of Psychedelic Drugs to Treat Depression

At Imperial College we’ve been comparing psilocybin to conventional antidepressants—and the results are likely to be game-changing.

Article
Robin Carhart-Harris
2020
FindCenter AddIcon
FindCenter Post-Image

Magic Mushrooms Expand the Mind by Dampening Brain Activity

A new brain-scan study helps explain how psilocybin works—and why it holds promise as a treatment for depression, addiction and post-traumatic stress.

Article
Maia Szalavitz
2012
FindCenter AddIcon
FindCenter Post-Image

The Future of Psychedelic Medicine

This is an exciting time to be involved in psychedelic research. Medical researchers are rediscovering the possible benefits of responsible use of psychedelics in therapeutic settings.

Article
Amanda Feilding
2017
FindCenter AddIcon
FindCenter Post-Image

Interview with Albert Hofmann, the Man Who First Synthesized LSD

The late chemist Albert Hofmann discussed his psychedelic research on LSD in the July, 1976 issue of High Times.

Article
High Times
2020
FindCenter AddIcon

EXPLORE TOPIC

Altered States of Consciousness